Skip to content
OpenCapital
Get started

Veracyte VCYT Business Segments — Compensation expense

Similar metrics at other companies

Clearwater Analytics logo
CWANReportable Segment — Employee compensation expense
$99.37M+78.0%
GRAIL, Inc. logo
GRALReportable Segment — Compensation
$62.78M-1.5%
Arcus Biosciences logo
RCUSReportable segment — Compensation and personnel costs
$70M+6.1%
YETI Holdings, Inc. logo
YETIReportable Segment — Compensation and benefits
$53.43M+7.2%
Indivior Pharmaceuticals, Inc. logo
INDVReportable Segment — Compensation expense related to stock-based payments
$9M+50.0%
e.l.f. Beauty logo
ELFReportable Segment — Compensation and benefits
$66.81M+59.0%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's business segments — compensation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's business segments — compensation expense?
Veracyte (VCYT) reported business segments — compensation expense of $19.97M in Q1 2026.
How has Veracyte's business segments — compensation expense changed year-over-year?
Veracyte's business segments — compensation expense decreased by 1.0% year-over-year, from $20.17M to $19.97M.
What is the long-term trend for Veracyte's business segments — compensation expense?
Over 3 years (2022 to 2025), Veracyte's business segments — compensation expense has grown at a 4.7% compound annual growth rate (CAGR), from $72.26M to $82.91M.
What does business segments — compensation expense mean?
Captures the total costs related to employee salaries, benefits, and stock-based compensation specifically attributable to the reportable segment. Monitoring this helps assess the segment's human capital investment and labor cost structure.